📣Announcing #ScientificSessions26 Late-Breaking Science. Join us in November to experience the highest tier of scientific discovery and practice-changing educational content. 📍Chicago, Nov 6-9 @JoChikweMD @bnallamo

From foundational science to clinical application, #ScientificSessions26 brings together the full spectrum of cardiovascular science under one roof. Register today: bit.ly/458Naqj

Science that moves the world forward starts here. Join global experts and thousands of cardiovascular professionals at #ScientificSessions26 in Chicago. Register now: bit.ly/458Naqj

📣Announcing #ScientificSessions26 Late-Breaking Basic Science Join us in November for unmatched access to groundbreaking research, dynamic learning and career-defining connections. @JoChikweMD @bnallamo 📍 Chicago, Nov 6-9

The traditional divide between cardiovascular and neurological disease may no longer reflect biological reality. Common cardiovascular conditions, including heart failure, atrial fibrillation, and myocardial infarction, are linked to cognitive impairment and mental health challenges, while stroke and severe psychological stress can contribute to cardiac dysfunction through bidirectional brain-heart pathways. This calls for integrated research, clinical trials, and care pathways that routinely consider cardiovascular, neurological, cognitive, and mental health outcomes together, reflecting the multidirectional nature of brain-heart disease. Read the perspective published in @Circaha written by @PeterPLiu_MD @MitchElkind and Roland von Känel here ahajournals.org/doi/10.1161/…

Registration is open for How Management has Changed and What You Need to Know: HFpEF + Diabetes + CKD 📅 Monday, Oct. 5 🕙 11a.m. CDT 💻 Live, real-world patient cases Expert faculty will share practical guidance on interpreting kidney markers, choosing evidence-based therapies and navigating the complexities of cardiovascular-kidney-metabolic (CKM) syndrome. The Primary Care Perspectives: Heart Failure in Primary Care initiative is supported by @Bayer. Register now: bit.ly/4waiuji

Congratulations to Jennifer S. Lawton, M.D., FAHA, recipient of the 2026 Basic Research Prize. An internationally recognized cardiac surgeon-scientist with @MarylandSurg, Dr. Lawton's pioneering translational research has advanced myocardial and neuroprotection during cardiac surgery, helping uncover novel strategies to protect the heart and brain while improving outcomes for patients undergoing complex cardiac procedures. Learn more: bit.ly/4cULCV4

Registration is open for How Management Has Changed and What You Need to Know: HFpEF + Diabetes + CKD. 📅 Monday, Oct. 5, 2026 🕚 11a.m. CDT 💻 Live webinar Explore real-world cases, evidence-based therapies and practical strategies across CKM syndrome. The Primary Care Perspectives: Heart Failure in Primary Care initiative is supported by @Bayer. Register: bit.ly/4zdPKc9

⏰ Last call for Case Study Submissions! Submit your science for #ISC27 before the deadline, Sept. 23 for the chance to be recognized. #ISC27 Chairs: @bijoymenon and @MarionBuckwalt2

The prevalence of advanced CKD is higher in women than in men; however, the mechanisms underlying this sex-specific disparity remain to be determined. Advancing precision kidney medicine for women requires equitable access to kidney care, embedding assessment of reproductive health in chronic care, trial design with adequate power that includes both women and men, and mechanistic studies linking reproductive health to long-term cardiovascular disease and CKD development and progression. professional.heart.org/en/sc… 📷 Challenges to women-specific kidney care

Globally, one in 10 women lives with chronic kidney disease (CKD), which is closely intertwined with cardiovascular risk as part of the cardiovascular-kidney-metabolic syndrome. This scientific statement highlights the pressing need for studying sex-specific pharmacokinetics and pharmacodynamics in CKD therapeutics to develop more sex-specific personalized drug dosing, selection, and risk management strategies. professional.heart.org/en/sc…

Published this week, State of Cardiovascular Disease and Stroke in Hispanic/Latino Adults in the United States A Scientific Statement from the American Heart Association Hispanic populations bear a disproportionate burden of chronic disease, including cardiovascular disease (CVD), driven by a high prevalence of cardiometabolic risk factors and persistent social and structural inequities. professional.heart.org/en/sc… 📷 Summary figure showing how personal, societal, and community factors influence cardiovascular risk factors and the development of cardiovascular disease in Hispanic populations.

Cardiovascular disease became the leading cause of death among Hispanic individuals in the United States in 2022. This scientific statement summarizes current CVD epidemiology in Hispanic populations, highlighting differences across heritage groups, the impact of social and structural determinants of health, and strategies to improve prevention and healthcare delivery. professional.heart.org/en/sc…

🔔Deadline Extended! There’s still time to apply for the Innovation Forum Early-Stage Pitch Showcase. Share your solution, gain exposure and connect with healthcare leaders on a national stage. ⏰New deadline: Sept. 18 at 5:00 PM CT. 🔗Apply now: bit.ly/4xubNKs

Where stroke and brain health science meet global collaboration. Join global experts and thousands of professionals at #ISC27 for cutting-edge science, practice-changing clinical insights and meaningful connections. #ISC27 Chairs: @bijoymenon and @MarionBuckwalt2 Register: bit.ly/46fswVS

The American Heart Association is proud to be part of this important work advancing responsible AI in cardiovascular care. We’re helping assess these emerging AI technologies in real-world settings, including rural and under-resourced communities, while contributing our expertise, data resources and national network to the effort. Together we can change the future of health for everyone, everywhere.